Magazine
As technology and psychedelics turn to mental health, we’ll likely see a future where we are treated based on our digital biomarkers, and sold mental health services based on the personal data we surrender.
Magazine
Psychedelic capitalists justify their decision to go for-profit in the ballroom of America’s most recent for-profit flop.
Magazine
After decades of psychedelic nonprofits paving regulatory pathways and priming wealthy investors, for-profits are moving in to reap the rewards.
Magazine
The new leaders of the psychedelic medicalization industry seem to see themselves as above their own self-proposed rules.
Magazine
“Play the field right and there’s money to be made even off some of the shit companies purely based on the wave.”
Magazine
Many predicted an ethical storm brewing in the lead-up to the explosion of for-profit interest in psychedelic pharmaceuticals. But, were their efforts to mitigate the damage enough to make a difference?